Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• FornerALlovetJMBruixJHepatocellular carcinomaLancet2012397982212451255
   Google Scholar
• ByamJRenzJMillisJMLiver transplantation for hepatocellular carcinomaHepatobiliary Surg Nutr201321223024570911
   PubMedGoogle Scholar
• SinghalAJayaramanMDhanasekaranDNKohliVMolecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrenceCrit Rev Oncol Hematol201282211614021680198
   PubMed Web of Science ®Google Scholar
• ChengALKangYKChenZEfficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialLancet Oncol2009101253419095497
   PubMed Web of Science ®Google Scholar
• KongHKParkSJKimYSEpigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinomaOncotarget2016734556775568927494879
   PubMedGoogle Scholar
• PaskaAVHudlerPAberrant methylation patterns in cancer: a clinical viewBiochem Med (Zagreb)201525216117626110029
   PubMedGoogle Scholar
• WuWRSunHZhangRMethylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1Oncotarget2016714186841869326919246
   PubMedGoogle Scholar
• RuanPShenJSantellaRMZhouSWangSNEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signalsNucleic Acids Res20164416e13427302130
   PubMedGoogle Scholar
• WangFFengYLiPRASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinomaOncotarget2016744279429726701853
   PubMedGoogle Scholar
• ZhuXShanLWangFHypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancerBreast Cancer Res Treat2015150347948625783183
   PubMed Web of Science ®Google Scholar
• LiQFLiQYGaoARShiQFCorrelation between promoter methylation in the GSTP1 gene and hepatocellular carcinoma development: a meta-analysisGenet Mol Res20151426762677226125884
   PubMedGoogle Scholar
• YamadaNYasuiKDohiOGenome-wide DNA methylation analysis in hepatocellular carcinomaOncol Rep20163542228223626883180
   PubMedGoogle Scholar
• ZhangXYouQZhangXChenXSOCS3 methylation predicts a poor prognosis in HBV infection-related hepatocellular carcinomaInt J Mol Sci2015169226622267526393582
   PubMedGoogle Scholar
• LvZZouHPengKThe suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinomaPLoS One2013810e7743724146994
   PubMedGoogle Scholar
• StefanskaBCheishviliDSudermanMGenome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targetsClin Cancer Res201420123118313224763612
   PubMedGoogle Scholar
• QiuXHuangYZhouYZhengFAberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implicationOncol Rep201636281181827373520
   PubMedGoogle Scholar
• SunFKSunQFanYCMethylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomyJ Gastroenterol Hepatol201631248449226313014
   PubMed Web of Science ®Google Scholar
• AshburnerMBallCABlakeJAGene ontology: tool for the unification of biology. The gene ontology consortiumNat Genet2000251252910802651
   PubMed Web of Science ®Google Scholar
• BarbanoRPalumboOPasculliBA miRNA signature for defining aggressive phenotype and prognosis in gliomasPLoS One2014910e10895025279461
   PubMedGoogle Scholar
• StefanskaBHuangJBhattacharyyaBDefinition of the landscape of promoter DNA hypomethylation in liver cancerCancer Res201171175891590321747116
   PubMedGoogle Scholar
• LiuKZhangYZhangCMethylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinomaOncotarget2016735567985681027462864
   PubMedGoogle Scholar
• LiWLiXWangWNOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinomaCarcinogenesis20113291305131421803736
   PubMedGoogle Scholar
• ZhangCPengYYangFQinRLiuWZhangCPCDH8 is frequently inactivated by promoter hypermethylation in liver cancer: diagnostic and clinical significanceJ Cancer20167444645226918058
   PubMedGoogle Scholar
• StefanskaBBouzelmatAHuangJDiscovery and validation of DNA hypomethylation biomarkers for liver cancer using HRM-specific probesPLoS One201388e6843923950870
   PubMedGoogle Scholar
• GranderDJohnssonPPseudogene-expressed RNAs: emerging roles in gene regulation and diseaseCurr Top Microbiol Immuol2016394111126
   PubMed Web of Science ®Google Scholar
• Kalyana-SundaramSKumar-SinhaCShankarSExpressed pseudogenes in the transcriptional landscape of human cancersCell201214971622163422726445
   PubMed Web of Science ®Google Scholar
• ByunDSChoKRyuBKFrequent monoallelic deletion of PTEN and its reciprocal association with PIK3CA amplification in gastric carcinomaInt J Cancer2003104331832712569555
   PubMed Web of Science ®Google Scholar
• HanLYuanYZhengSThe pan-cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypesNat Commun20145396324999802
   PubMed Web of Science ®Google Scholar
• YuGYaoWGumireddyKPseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progressionMol Cancer Ther201413123086309725249556
   PubMed Web of Science ®Google Scholar
• LeonardWJSpolskiRInterleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiationNat Rev Immunol20055968869816138102
   PubMedGoogle Scholar
• BhattSMatthewsJParvinSDirect and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphomaBlood2015126131555156426194763
   PubMedGoogle Scholar
• ChenYLChouCYChangMCIL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patientsEndocr Relat Cancer201522570371126150382
   PubMedGoogle Scholar
• KulisMEstellerMDNA methylation and cancerAdv Genet201070275620920744
   PubMed Web of Science ®Google Scholar
• HaradaKBabaYIshimotoTLINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomasAnn Surg Oncol20152241280128725319577
   PubMed Web of Science ®Google Scholar
• LiuPJiangWRenHZhangHHaoJExploring the molecular mechanism and biomakers of liver cancer based on gene expression microarrayPathol Oncol Res20152141077108325907256
   PubMedGoogle Scholar
• WieseHGelisLWieseSQuantitative phosphoproteomics reveals the protein tyrosine kinase Pyk2 as a central effector of olfactory receptor signaling in prostate cancer cellsBiochim Biophys Acta20151854663264025219547
   PubMed Web of Science ®Google Scholar
• FeldmesserEOlenderTKhenMWidespread ectopic expression of olfactory receptor genesBMC Genomics2006712116716209
   PubMed Web of Science ®Google Scholar
• MassbergDSimonAHaussingerDYanaiIOphirRLancetDMonoterpene (−)-citronellal affects hepatocarcinoma cell signaling via an olfactory receptorArch Biochem Biophy2015566100109
   PubMed Web of Science ®Google Scholar
• ManteniotisSWojcikSBrauhoffPFunctional characterization of the ectopically expressed olfactory receptor 2AT4 in human myelogenous leukemiaCell Death Discov201621507027551494
   PubMed Web of Science ®Google Scholar
• KimBKHanKHAhnSHPrevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infectionOncology201181 Suppl 1414922212935
   PubMedGoogle Scholar
• McGlynnKALondonWTThe global epidemiology of hepatocellular carcinoma: present and futureClin Liver Dis201115222324321689610
   PubMed Web of Science ®Google Scholar